Cargando…
Polymeric Nanoscale Drug Carriers Mediate the Delivery of Methotrexate for Developing Therapeutic Interventions Against Cancer and Rheumatoid Arthritis
Methotrexate (MTX) is widely used as an anticancer and anti-inflammtory drug for treating various types of cancer and autoimmune diseases. The optimal dose of MTX is known to inhibit the dihydrofolatereductase that hinders the replication of purines. The nanobiomedicine has been extensively explored...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526065/ https://www.ncbi.nlm.nih.gov/pubmed/33042817 http://dx.doi.org/10.3389/fonc.2020.01734 |
_version_ | 1783588798696783872 |
---|---|
author | Yu, Wen-Jun Huang, Dong-Xu Liu, Shuang Sha, Ying-Li Gao, Feng-hui Liu, Hong |
author_facet | Yu, Wen-Jun Huang, Dong-Xu Liu, Shuang Sha, Ying-Li Gao, Feng-hui Liu, Hong |
author_sort | Yu, Wen-Jun |
collection | PubMed |
description | Methotrexate (MTX) is widely used as an anticancer and anti-inflammtory drug for treating various types of cancer and autoimmune diseases. The optimal dose of MTX is known to inhibit the dihydrofolatereductase that hinders the replication of purines. The nanobiomedicine has been extensively explored in the past decade to develop myriad functional nanostructures to facilitate the delivery of therapeutic agents for various medical applications. This review is focused on understanding the design and development of MTX-loaded nanoparticles alongside the inclusion of recent findings for the treatment of cancers. In this paper, we have made a coordinated effort to show the potential of novel drug delivery systems by achieving effective and target-specific delivery of methotrexate. |
format | Online Article Text |
id | pubmed-7526065 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75260652020-10-09 Polymeric Nanoscale Drug Carriers Mediate the Delivery of Methotrexate for Developing Therapeutic Interventions Against Cancer and Rheumatoid Arthritis Yu, Wen-Jun Huang, Dong-Xu Liu, Shuang Sha, Ying-Li Gao, Feng-hui Liu, Hong Front Oncol Oncology Methotrexate (MTX) is widely used as an anticancer and anti-inflammtory drug for treating various types of cancer and autoimmune diseases. The optimal dose of MTX is known to inhibit the dihydrofolatereductase that hinders the replication of purines. The nanobiomedicine has been extensively explored in the past decade to develop myriad functional nanostructures to facilitate the delivery of therapeutic agents for various medical applications. This review is focused on understanding the design and development of MTX-loaded nanoparticles alongside the inclusion of recent findings for the treatment of cancers. In this paper, we have made a coordinated effort to show the potential of novel drug delivery systems by achieving effective and target-specific delivery of methotrexate. Frontiers Media S.A. 2020-09-16 /pmc/articles/PMC7526065/ /pubmed/33042817 http://dx.doi.org/10.3389/fonc.2020.01734 Text en Copyright © 2020 Yu, Huang, Liu, Sha, Gao and Liu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Yu, Wen-Jun Huang, Dong-Xu Liu, Shuang Sha, Ying-Li Gao, Feng-hui Liu, Hong Polymeric Nanoscale Drug Carriers Mediate the Delivery of Methotrexate for Developing Therapeutic Interventions Against Cancer and Rheumatoid Arthritis |
title | Polymeric Nanoscale Drug Carriers Mediate the Delivery of Methotrexate for Developing Therapeutic Interventions Against Cancer and Rheumatoid Arthritis |
title_full | Polymeric Nanoscale Drug Carriers Mediate the Delivery of Methotrexate for Developing Therapeutic Interventions Against Cancer and Rheumatoid Arthritis |
title_fullStr | Polymeric Nanoscale Drug Carriers Mediate the Delivery of Methotrexate for Developing Therapeutic Interventions Against Cancer and Rheumatoid Arthritis |
title_full_unstemmed | Polymeric Nanoscale Drug Carriers Mediate the Delivery of Methotrexate for Developing Therapeutic Interventions Against Cancer and Rheumatoid Arthritis |
title_short | Polymeric Nanoscale Drug Carriers Mediate the Delivery of Methotrexate for Developing Therapeutic Interventions Against Cancer and Rheumatoid Arthritis |
title_sort | polymeric nanoscale drug carriers mediate the delivery of methotrexate for developing therapeutic interventions against cancer and rheumatoid arthritis |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526065/ https://www.ncbi.nlm.nih.gov/pubmed/33042817 http://dx.doi.org/10.3389/fonc.2020.01734 |
work_keys_str_mv | AT yuwenjun polymericnanoscaledrugcarriersmediatethedeliveryofmethotrexatefordevelopingtherapeuticinterventionsagainstcancerandrheumatoidarthritis AT huangdongxu polymericnanoscaledrugcarriersmediatethedeliveryofmethotrexatefordevelopingtherapeuticinterventionsagainstcancerandrheumatoidarthritis AT liushuang polymericnanoscaledrugcarriersmediatethedeliveryofmethotrexatefordevelopingtherapeuticinterventionsagainstcancerandrheumatoidarthritis AT shayingli polymericnanoscaledrugcarriersmediatethedeliveryofmethotrexatefordevelopingtherapeuticinterventionsagainstcancerandrheumatoidarthritis AT gaofenghui polymericnanoscaledrugcarriersmediatethedeliveryofmethotrexatefordevelopingtherapeuticinterventionsagainstcancerandrheumatoidarthritis AT liuhong polymericnanoscaledrugcarriersmediatethedeliveryofmethotrexatefordevelopingtherapeuticinterventionsagainstcancerandrheumatoidarthritis |